News from the healthcare data industry
June 07, 2022 08:00 AM Eastern Daylight Time RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced the appointment of Dr. Christina Mack to serve as chief scientific officer for the company’s Real World…
Paris, June 8, 2022. Sanofi announces the launch of its first Digital Accelerator to foster its ambition to become a leading digital healthcare company. The Accelerator will develop products and solutions that will support Sanofi’s mission to transform the practice of medicine with the use of digital, data and artificial…
June 8, 2022 Michael Howley PA-C, MBA, PhD, Peter Malamis, MBA Survey taken by pharma and CRO executives evaluates how effectively various programs convert RWD into usable data. We have previously described that real-world data has mediocre usage in the clinical trials despite enthusiasm for these analytics and their performance in…
SAN FRANCISCO and FORT LAUDERDALE, Fla., June 07, 2022 (GLOBE NEWSWIRE) — The COVID-19 Research Database (the Database), a pro bono initiative led by numerous prominent companies whose mission is to accelerate real world pandemic research to understand the disease and inform evidence-based healthcare policy, today announced a partnership with…
Singapore – 7 June 2022: GE Healthcare today announces a new collaboration with National Cancer Centre Singapore (NCCS), which focuses on how artificial intelligence (AI) driven research can be used to improve cancer care. The collaboration is the first of its kind for GE Healthcare in the Asia-Pacific (APAC) region and…
CHICAGO, June 7, 2022 /PRNewswire/ — EVERSANA™, a pioneer of next-generation commercial services to the global life sciences industry, today unveiled EVERSANA INTOUCH, marking the transformation of its full-service, global healthcare agency network serving the life sciences industry. Combining the power of world-class creative, media and digital innovation with payer, patient, and healthcare communications expertise,…
Global healthcare data management and analytics leader brings together experts to discuss current drivers in personalized medicine at second edition of Precision Medicine & Data Science Conference in Singapore ZURICH, June 6, 2022 /PRNewswire/ — BC Platforms (BCP), a leading provider of data and technology platforms for personalized medicine and drug development, will host a key, day-long, Precision Medicine…
Initial Goal of Collaboration is to Develop FoundationOne®Liquid CDx as a Companion Diagnostic for Bavdegalutamide (ARV-110), Arvinas’ Investigational Androgen Receptor-Targeting PROTAC® Protein Degrader June 05, 2022 08:05 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Today Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, announced a collaboration with Arvinas, Inc.,…
NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) today announced overall survival (OS) results from the Phase 3 PALOMA-2 trial, which evaluated IBRANCE® (palbociclib) in combination with letrozole compared to placebo plus letrozole for the first-line treatment of postmenopausal women with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) metastatic…
COBALT study in advanced PBC, previously terminated early due to feasibility challenges, did not demonstrate a statistically significant difference in clinical endpoints between Ocaliva® and placebo HEROES-US real-world analysis demonstrated statistically significant improvement in event-free survival in patients receiving Ocaliva for PBC Intercept plans to include these data in an evidence…